Credit Suisse Assesses St. Jude Medical (STJ) Risk; Says Product Removal Unlikely But Could Be Grounds for Abbott to Exit or Lower Bid
Tweet Send to a Friend
Credit Suisse analyst Matthew Keeler assessed the risk surrounding St. Jude Medical (NYSE: STJ) after Muddy Waters issued a new ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
